Zhang R, Mylonakis E. In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon beta-1a differed from standard care for in-hospital mortality. Ann Intern Med 2021 Feb 2. doi: 10.7326/ACPJ202102160.
PMID: 33524282